semaglutide ckd trial Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT 🚨 Journal Club: FLOW Trial

These critical modifications confer a slightly higher affinity to the GLP-1 receptor for both peptides, enabling lower concentrations to achieve equivalent receptor occupancy compared to native GLP-1 [13]

* Helps balance hunger hormones to increase satiety via gut-brain axis, so you feel fuller, longer* Helps maintain blood sugar levels already within a normal healthy range* Features MB Enhance supplies 48% of daily dietary fiber

It also reduces hunger and cravings by releasing hormones that make you feel full

These changes are manageable and temporary

10.1161/JAHA.118.011630 215 Murawska-CiaowiczE.de AssisG

Seniors may have more medical variables, so it's smart to confirm fitespecially if appetite, kidneys, or digestion are changing